Expression of intrarenal wnt3a and active-β-catenin, measured by both immunohistochemistry and western blot, was up-regulated significantly after 5/6NX operation, indicating activation of intrarenal wnt/β-catenin signaling in CKD (Fig. 5). Here, WNT3A is linked to chronic kidney disease.